Table 1.
PEDro scale score table
| Study | EC | RD | CN | BL | SB | TB | AB | MO | IT | BG | ES | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aline Barbosa et al. [33] | Y | N | N | Y | N | N | N | Y | Y | N | Y | 5 |
| Abdel-Aziem et al. [34] | Y | N | N | Y | N | N | N | Y | Y | Y | Y | 6 |
| Souza et al.[35] | Y | Y | N | Y | N | N | N | Y | Y | Y | Y | 7 |
| Cheol-Jin Kwak et al. [36] | Y | N | N | Y | N | N | N | Y | Y | Y | Y | 6 |
| Chinnavan et al. [37] | Y | Y | N | Y | N | N | N | Y | Y | N | Y | 6 |
| Christou et al. [38] | Y | N | N | Y | N | N | N | Y | Y | Y | Y | 6 |
| Da Costa et al. [39] | Y | N | N | Y | N | N | N | N | Y | Y | Y | 5 |
| Da Cruz et al. [40] | Y | Y | N | Y | N | N | N | Y | Y | Y | Y | 7 |
| de Oliveira et al. [41] | Y | Y | Y | Y | N | N | Y | Y | Y | Y | Y | 9 |
| Cyrino et al. [42] | Y | Y | N | Y | N | N | N | Y | Y | Y | Y | 7 |
| Faigenbaum et al. [23] | Y | Y | N | Y | N | N | N | Y | Y | Y | Y | 7 |
| Faigenbaum et al. [24] | Y | N | N | Y | N | N | N | Y | Y | Y | Y | 6 |
| Faigenbaum et al. [43] | Y | N | N | Y | N | N | N | Y | Y | Y | Y | 6 |
| Fatouros et al. [44] | Y | Y | N | Y | N | N | N | Y | Y | Y | Y | 7 |
| Fatouros et al. [45] | Y | Y | N | Y | N | N | N | Y | Y | Y | Y | 7 |
| Fourie et al. [46] | Y | Y | N | Y | N | N | N | Y | Y | N | Y | 6 |
| François Delvaux et al. [47] | Y | Y | Y | Y | N | N | Y | Y | Y | N | Y | 8 |
| Fritz et al. [48] | Y | Y | N | Y | N | N | N | N | Y | Y | Y | 6 |
| González-Gálvez et al. [49] | Y | Y | N | Y | N | N | N | Y | Y | Y | Y | 7 |
| Greco et al. [50] | Y | Y | N | Y | N | N | N | Y | Y | Y | Y | 7 |
| Greco et al. [51] | Y | N | N | N | N | N | N | Y | Y | Y | Y | 5 |
| Guex et al. [52] | Y | Y | N | Y | N | N | N | Y | Y | Y | Y | 7 |
| Elsangedy et al. [53] | Y | Y | N | Y | N | N | N | Y | Y | Y | Y | 7 |
| Ribeiro-Alvares et al. [54] | Y | Y | N | Y | N | N | N | Y | Y | Y | Y | 7 |
| Junior et al. [55] | Y | N | N | Y | N | N | N | Y | Y | Y | Y | 6 |
| Kalapotharakos et al. [56] | Y | Y | N | Y | N | N | N | Y | Y | Y | Y | 7 |
| Kao et al. [57] | Y | N | N | Y | N | N | N | Y | Y | Y | Y | 6 |
| Kiliç and Hinçal [58] | N | N | N | Y | N | N | N | Y | Y | N | Y | 4 |
| Kim et al. [22] | Y | Y | N | Y | N | N | N | Y | Y | Y | Y | 7 |
| Kloubec et al. [59] | N | Y | N | Y | N | N | N | Y | Y | N | Y | 5 |
| Lee et al. [60] | Y | Y | N | Y | N | N | N | Y | Y | Y | Y | 7 |
| Leite et al. [61] | Y | Y | N | Y | N | N | N | Y | Y | Y | Y | 7 |
| Kovách et al. [62] | Y | Y | N | Y | N | N | N | Y | Y | Y | Y | 7 |
| Manshouri et al. [63] | N | Y | N | Y | N | N | N | Y | Y | N | N | 4 |
| Monteiro et al. [64] | Y | Y | N | Y | N | N | N | Y | Y | Y | Y | 7 |
| Moraes et al. [26] | Y | Y | N | Y | N | N | N | Y | Y | Y | Y | 7 |
| Morton et al. [20] | N | Y | N | Y | N | N | N | Y | Y | Y | Y | 6 |
| Mueller et al. [65] | Y | Y | N | Y | N | N | N | Y | Y | Y | Y | 7 |
| Nelson and Bandy [19] | Y | Y | N | Y | N | N | N | Y | Y | Y | Y | 7 |
| Nobuo Takeshima et al. [66] | Y | N | N | Y | N | N | N | Y | Y | Y | Y | 6 |
| Ruslan et al. [67] | Y | Y | N | Y | N | N | N | Y | Y | Y | Y | 7 |
| Potier et al. [68] | Y | Y | N | Y | N | N | N | Y | Y | N | Y | 6 |
| Rayes et al. [69] | Y | Y | Y | Y | N | N | N | N | Y | Y | Y | 7 |
| Reinold et al. [70] | Y | Y | N | Y | N | N | N | Y | Y | Y | Y | 7 |
| Sima˜O et al. [25] | Y | Y | N | Y | N | N | N | Y | Y | Y | Y | 7 |
| Rok Vatovec et al. [71] | Y | Y | N | Y | N | N | N | Y | Y | Y | Y | 7 |
| Santos et al. [72] | Y | N | N | Y | N | N | N | Y | Y | Y | Y | 6 |
| Saraiva et al. [73] | Y | N | N | Y | N | N | N | Y | Y | Y | Y | 6 |
| Sekendiz et al. [74] | Y | Y | N | Y | N | N | N | Y | Y | Y | Y | 7 |
| Sinđić et al. [75] | Y | Y | N | Y | N | N | N | Y | Y | Y | Y | 7 |
| Phrompaet et al. [76] | Y | Y | Y | Y | N | N | Y | Y | Y | Y | Y | 9 |
| Swank et al. [77] | Y | N | N | N | N | N | N | Y | Y | Y | Y | 5 |
| Versic et al. [78] | Y | N | N | Y | N | N | N | Y | Y | Y | Y | 6 |
| Wyon et al. [21] | N | Y | Y | Y | N | N | N | Y | Y | Y | Y | 7 |
| Yaprak et al. [79] | Y | Y | N | Y | N | N | N | Y | Y | Y | Y | 7 |
| Mean | 6.5 | |||||||||||
| Median | 7 | |||||||||||
| Mode | 7 |
PEDro scale criteria: AB there was blinding of all assessors who measured at least one key outcome, BG the results of between-group statistical comparisons were reported for at least one key outcome, BL the groups were similar at baseline regarding the most important prognostic indicators, CS allocation was concealed, EC eligibility criteria were specified, ES the study provided both point measures and measures of variability for at least one key outcome, IT all subjects for whom outcome measures were available received the treatment or control condition as allocated or, where this was not the case, data for at least one key outcome were analyzed by “intention to treat”, MO measures of at least one key outcome were obtained from more than 85% of the subjects initially allocated to groups, N no, RD subjects were randomly allocated to groups (in a crossover study, subjects were randomly allocated an order in which treatments were received), SB there was blinding of all subjects, TB there was blinding of all therapists/researchers who administered the therapy/protocol, Y yes